JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.56B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.56B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.17B |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$777M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.82B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.38B |
| 3 |
Apple
AAPL
|
+$977M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$915M |
| 5 |
Walt Disney
DIS
|
+$778M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.46% |
| 2 | Technology | 11.62% |
| 3 | Healthcare | 10.99% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Industrials | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Arcosa
ACA
$7.13B
| $2.54M | ﹤0.01% |
+91,724
| New | +$2.52M |
|
2977
Voya Financial
VOYA
$9.01B
| $2.54M | ﹤0.01% |
63,209
-1,141,254
| -95% | -$50.7M |
|
2978
Apogee Enterprises
APOG
$826M
| $2.54M | ﹤0.01% |
84,911
-50,384
| -37% | -$1.81M |
|
|
SFUN
2979
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $2.52M | ﹤0.01% |
35,267
+22,219
| +170% | +$2.1M |
|
2980
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.5B
| $2.52M | ﹤0.01% |
117,595
+5,555
| +5% | +$129K |
|
|
ADAP
2981
DELISTED
Adaptimmune Therapeutics
ADAP
| $2.51M | ﹤0.01% |
436,278
+287,753
| +194% | +$2.12M |
|
|
SC
2982
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $2.5M | ﹤0.01% |
142,444
-228,842
| -62% | -$4.25M |
|
2983
PUT
Editas Medicine
EDIT
$396M
| $2.5M | ﹤0.01% |
+110,000
| New | +$2.99M |
|
|
FINV
2984
FinVolution Group
FINV
$1.15B
| $2.5M | ﹤0.01% |
694,556
-157,146
| -18% | -$840K |
|
|
NGHC
2985
DELISTED
National General Holdings Corp
NGHC
| $2.5M | ﹤0.01% |
103,254
+20,606
| +25% | +$524K |
|
2986
CALL
ConocoPhillips
COP
$147B
| $2.49M | ﹤0.01% |
40,000
+15,500
| +63% | +$1.05M |
|
|
SGI
2987
PUT
Somnigroup International
SGI
$13.7B
| $2.48M | ﹤0.01% |
+240,000
| New | +$2.88M |
|
|
CBAY
2988
DELISTED
Cymabay Therapeutics
CBAY
| $2.48M | ﹤0.01% |
315,726
+302,078
| +2,213% | +$2.88M |
|
|
DVAX
2989
DELISTED
Dynavax Technologies
DVAX
| $2.48M | ﹤0.01% |
270,575
+5,906
| +2% | +$65.4K |
|
2990
Cannae Holdings
CNNE
$639M
| $2.47M | ﹤0.01% |
144,479
-190,528
| -57% | -$3.43M |
|
2991
OceanFirst Financial
OCFC
$1.68B
| $2.47M | ﹤0.01% |
109,756
+2,772
| +3% | +$69.5K |
|
|
GCAP
2992
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $2.46M | ﹤0.01% |
399,950
+143,971
| +56% | +$1.05M |
|
2993
Vanguard Total World Stock ETF
VT
$77.1B
| $2.46M | ﹤0.01% |
37,625
+10,978
| +41% | +$768K |
|
2994
TriMas Corp
TRS
$1.43B
| $2.46M | ﹤0.01% |
90,006
+2,714
| +3% | +$77.3K |
|
2995
Cavco Industries
CVCO
$4.22B
| $2.45M | ﹤0.01% |
18,792
+10,491
| +126% | +$1.9M |
|
2996
3D Systems Corp
DDD
$431M
| $2.45M | ﹤0.01% |
240,796
+211,728
| +728% | +$2.9M |
|
|
GG.WS.A
2997
PUT
DELISTED
GOLDCORP INC SERIES A WARRANTS EXP 5/30/2007
GG.WS.A
| $2.45M | ﹤0.01% |
250,000
| – | – |
|
|
DMC
2998
Del Monte Corp
DMC
$1.41B
| $2.44M | ﹤0.01% |
86,215
-1,447
| -2% | -$45.4K |
|
|
AIMT
2999
CALL
DELISTED
Aimmune Therapeutics
AIMT
| $2.44M | ﹤0.01% |
+101,800
| New | +$2.63M |
|
3000
Under Armour
UAA
$2.84B
| $2.43M | ﹤0.01% |
137,664
+1,736
| +1% | +$35.6K |
|
Similar funds
JP Morgan Chase's Q4 2018 Portfolio in Review
As of Q4 2018, JP Morgan Chase held 6,191 positions worth $432B, down 17% from $522B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase withdrew a net $17.1B in Q4 2018, closing 424 positions and reducing 2,219 holdings. Its most notable exit was Energen, an estimated $648M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.
Against the trend, JP Morgan Chase opened a new position in Linde worth $751M.
- JP Morgan Chase's largest Q4 2018 buy was Linde: 4,813,392 shares worth $751M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2018, an estimated $1.56B increase.
- JP Morgan Chase's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.82B.
- JP Morgan Chase fully exited Energen in Q4 2018, selling an estimated $648M.
- JP Morgan Chase's ten largest holdings make up 16% of its $432B portfolio in Q4 2018.
- JP Morgan Chase opened 487 new positions and closed 424 in Q4 2018.
- JP Morgan Chase's portfolio value fell 17% quarter-over-quarter to $432B.
Based on JP Morgan Chase's 13F filing for Q4 2018, filed 11 Feb 2019.